International University of Health and Welfare · Faculty of Medicine · 教授

Research keywords2型糖尿病・糖尿病性心筋症・12-HETE・12-lipoxygenase・心筋梗塞後リモデリング・CGM・ABPM・sitagliptin glucose lowering・圧受容器反射感受性

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite
• Cardiac 12-Lipoxygenase-Induced Oxidative Stress Promotes the Development of Diabetic Card iomyopathy
• Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report.
• Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.

• 糖尿病合併心不全における12-リポキシゲナーゼの役割
• 糖尿病における圧受容器機能低下が心筋細胞へ与える影響の解明
• 糖尿病性心筋症の発症における12-Lipoxygenaseのシグナル伝達機構
• 2型糖尿病患者の心血管イベント防止を目指した新規コントロール基準の作成

• Official profile
• ORCID